Floatz logo

emb07

EMB07

Shanghai EpimAb Biotherapeutics Co., Ltd.Phase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the EMB07 cohort.

Asset / SponsorPhaseRating
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Shanghai EpimAb Biotherapeutics Co., Ltd.
Phase 1/2CCC
Eloxatin
Shanghai EpimAb Biotherapeutics Co., Ltd.
Phase 1/2CCC

Same molecule, other indications

emb07 is also rated in:

Combination TherapyDormant
CCC
Indicative ·
48 / 100
View asset →
phaseI/IIDormant
CCC
Indicative ·
48 / 100
View asset →
aggressive B-cell non-Hodgkin lymphomaDormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →